OTL-204

N/A

Report date: 2025/01/02 16:12:00

Base Information

Drug NameOTL-204
Drug Alias NameOTL-204
ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionProgranulin gene transference
TargetsProgranulin
Therapy Area/IndicationsFrontotemporal Dementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Padua
China Registration ClassN/A

Develop Information

Active CompaniesOrchard Therapeutics Plc
Inactive CompaniesN/A
Active IndicationsFrontotemporal Dementia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A